[ad_1] Metformin is the most commonly prescribed glucose-lowering medicine in the world, and it is frequently used as a first-line treatment for type 2 diabetes. Although the medicine is currently only officially approved by the U.S. Food and Drug Administration (FDA) for treating type 2 diabetes, you may have heard about people with type 1 … Read more
[ad_1] Exercising with type 1 diabetes isn’t simple — but it is doable if you learn the essential science of juggling insulin, timing, nutrition, and aerobic vs. anaerobic exercise. Here’s a closer look at exercising safely with type 1 diabetes with excerpts from my book Exercise with Type 1 Diabetes. How much exercise do you … Read more
[ad_1] Metformin is a popular prescription drug that is used as a first-line treatment for prediabetes and type 2 diabetes. It is typically taken orally, in the form of a pill, once or twice each day. Metformin helps people manage their blood sugar levels. It is thought to work by decreasing the release of glucose … Read more
[ad_1] Learning from an MSc Physiotherapy Student Placement in a specialist dementia ward in Dumfries. Hi, my name is Diarmuid and along with my fellow MSc Physiotherapy classmate Chloe, we embarked on a placement experience that would forever shape our perspective on healthcare and human connection. Our time in a specialist dementia ward was a … Read more
[ad_1] A Unique Model: Individualized Memory Care for All Income Levels At Rakhma Homes. November 16, 2023 by Alzheimer’s Speaks Lori La Bey talks with the team at Rakhma Homes, which are small group homes providing care to those living with dementia. Their unique model of care is worth listening to today on how and why … Read more
[ad_1] DISCERN™, A Highly Accurate, Minimally Invasive Test To Diagnose Alzheimer’s Disease November 14, 2023 by Alzheimer’s Speaks Frank Amato, CEO and President, SYNAPS Dx, which offers DISCERN™, the first highly accurate, minimally invasive test supporting a clinician’s definitive diagnosis of AD versus other forms of dementia, even in people recently diagnosed with dementia. DISCERN is … Read more